IS4932A - Ný efnasambönd - Google Patents

Ný efnasambönd

Info

Publication number
IS4932A
IS4932A IS4932A IS4932A IS4932A IS 4932 A IS4932 A IS 4932A IS 4932 A IS4932 A IS 4932A IS 4932 A IS4932 A IS 4932A IS 4932 A IS4932 A IS 4932A
Authority
IS
Iceland
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IS4932A
Other languages
English (en)
Icelandic (is)
Inventor
Bantick John
Perry Matthew
Thorne Philip
Original Assignee
Astra Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614360.7A external-priority patent/GB9614360D0/en
Priority claimed from GBGB9626884.2A external-priority patent/GB9626884D0/en
Application filed by Astra Pharmaceuticals Ltd. filed Critical Astra Pharmaceuticals Ltd.
Publication of IS4932A publication Critical patent/IS4932A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
IS4932A 1996-07-09 1998-12-23 Ný efnasambönd IS4932A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9614360.7A GB9614360D0 (en) 1996-07-09 1996-07-09 Compounds
GBGB9626884.2A GB9626884D0 (en) 1996-12-24 1996-12-24 Compounds
PCT/SE1997/001219 WO1998001449A1 (en) 1996-07-09 1997-07-04 Novel compounds

Publications (1)

Publication Number Publication Date
IS4932A true IS4932A (is) 1998-12-23

Family

ID=26309668

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4932A IS4932A (is) 1996-07-09 1998-12-23 Ný efnasambönd

Country Status (16)

Country Link
EP (1) EP0915879A1 (es)
JP (1) JP2000516206A (es)
KR (1) KR20000023644A (es)
AR (1) AR008395A1 (es)
AU (1) AU708882B2 (es)
BR (1) BR9710215A (es)
CA (1) CA2260057A1 (es)
CZ (1) CZ3699A3 (es)
EE (1) EE9900012A (es)
ID (1) ID18889A (es)
IL (1) IL127690A0 (es)
IS (1) IS4932A (es)
NO (1) NO990072D0 (es)
PL (1) PL331090A1 (es)
TR (1) TR199900013T2 (es)
WO (1) WO1998001449A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04001400A (es) * 2001-08-13 2004-05-27 Janssen Pharmaceutica Nv Derivados de tiazolilo 2,4,5-tri-substituidos y su actividad anti-inflamatoria.
EP2504871B1 (en) 2009-11-24 2017-03-22 Novaled GmbH Organic electronic device comprising an organic semiconducting material
US20150311450A1 (en) * 2012-11-30 2015-10-29 Lg Chem, Ltd. New compounds and organic electronic device using the same
KR102153040B1 (ko) 2013-11-28 2020-09-07 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
KR102427034B1 (ko) 2016-04-22 2022-07-29 바이압틱스 인코포레이티드 절대적인 및 상대적인 조직 산소 포화도의 결정
CN108484606B (zh) * 2018-03-16 2020-03-06 江南大学 一种嘧啶并[4,5-f]喹唑啉类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670577A1 (de) * 1967-10-05 1971-05-19 Akad Wissenschaften Ddr Verfahren zur Herstellung von 5-oxo-5.6.7.8-tetrahydro-chinazelinen
US4272535A (en) * 1978-07-31 1981-06-09 Schering Corporation 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists

Also Published As

Publication number Publication date
EP0915879A1 (en) 1999-05-19
JP2000516206A (ja) 2000-12-05
IL127690A0 (en) 1999-10-28
ID18889A (id) 1998-05-20
PL331090A1 (en) 1999-06-21
EE9900012A (et) 1999-06-15
BR9710215A (pt) 1999-08-10
AU708882B2 (en) 1999-08-12
CA2260057A1 (en) 1998-01-15
TR199900013T2 (xx) 1999-04-21
NO990072D0 (no) 1999-01-08
CZ3699A3 (cs) 1999-06-16
WO1998001449A1 (en) 1998-01-15
AU3711697A (en) 1998-02-02
KR20000023644A (ko) 2000-04-25
AR008395A1 (es) 2000-01-19

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
IS5354A (is) Ný efnasambönd
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
BR9710352A (pt) Compostos piridilpirrole
BR9707051A (pt) Composto
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18685A (id) Senyawa trisiklik tersubstitusi
PT906288E (pt) Novos compostos
BR9705635A (pt) Compostos
BR9711205A (pt) Composto
DK0923594T3 (da) Bromotiacumicinforbindelser
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
IS4932A (is) Ný efnasambönd
BR9711681A (pt) Novos m-todos
SE9603464D0 (sv) New compounds
SE9603470D0 (sv) New compounds
SE9601787D0 (sv) New compounds
SE9603505D0 (sv) New compounds
SE9600555D0 (sv) New compounds
SE9604785D0 (sv) New compounds
SE9604787D0 (sv) New compounds